Trevena, Inc.
Biotechnology ResearchPennsylvania, United States11-50 Employees
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
Innovative CNS Focus Trevena specializes in the development of novel medicines for central nervous system disorders, presenting opportunities to collaborate with healthcare providers and institutions seeking advanced CNS therapeutics and research partnerships.
Strategic Funding and Growth Recent financing of four million dollars indicates potential for expansion and increased R&D activities, making Trevena an attractive partner for investors and organizations interested in early-stage biotech collaborations.
Pipeline Advancement With multiple clinical and proof-of-concept studies, including TRV045 and OLINVYK, Trevena is progressing toward innovative CNS treatment options, creating opportunities for medical device companies, contract research organizations, and suppliers involved in clinical development.
Tech-Enabled Operations Utilizing advanced cloud and web technologies like Cloudflare, NetSuite, and Google Fonts API, Trevena demonstrates a modern, digitally integrated approach, suggesting opportunities for technology providers and digital service partnerships to optimize biotech operations.
Collaborative Research Initiatives Partnerships with organizations such as the National Institute on Drug Abuse highlight Trevena's focus on opioid use disorder treatment, creating potential for strategic alliances with government agencies, healthcare providers, and organizations involved in addiction therapy and mental health solutions.
Trevena, Inc. uses 8 technology products and services including Cloudflare, NetSuite, SparkPost, and more. Explore Trevena, Inc.'s tech stack below.
| Trevena, Inc. Email Formats | Percentage |
| FLast@trevena.com | 81% |
| First.Last@trevena.com | 12% |
| FirstLast@trevena.com | 5% |
| First@trevena.com | 2% |
Biotechnology ResearchPennsylvania, United States11-50 Employees
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
Trevena, Inc. has raised a total of $2M of funding over 19 rounds. Their latest funding round was raised on Jul 08, 2024 in the amount of $2M.
Trevena, Inc.'s revenue is estimated to be in the range of $1M$10M
Trevena, Inc. has raised a total of $2M of funding over 19 rounds. Their latest funding round was raised on Jul 08, 2024 in the amount of $2M.
Trevena, Inc.'s revenue is estimated to be in the range of $1M$10M